This creates a bimodal distribution, with lots of very happy users and lots of very unhappy users, but relatively few in the middle
Our expert team will assess your unique needs and work with you to determine if GLP-1 therapy is right for you, alongside practical advice on nutrition, lifestyle changes, and ongoing support
The product information of the Food and Drug Administration (FDA, accessdata.fda.gov) and European Medicine Agency (EMA, ema.europa.eu) on all GLP-1 agonists and SGLT2 inhibitors were searched for additional data
Plaintiffs allege that Novo Nordisk, the drugs manufacturer, did not adequately warn users and healthcare providers about these risks
Even a small reduction in weight can have a significant impact on blood sugar control and overall health
Dec 21 [cited 2024 Feb 28]